The Analgesic Efficacy of Adding the iPACK Block to a Multimodal Analgesia Protocol for Primary Total Knee Arthroplasty (TKA)
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 12/21/2018 |
| Start Date: | July 1, 2018 |
| End Date: | March 1, 2020 |
| Contact: | Rupa Chowdary |
| Email: | rupa.chowdary@uphs.upenn.edu |
| Phone: | 215-615-4105 |
The Analgesic Efficacy of Adding the IPACK Block to a Multimodal Analgesia Protocol for Primary Total Knee Arthroplasty
This is a perspective, randomized, blinded study with a parallel design and an allocation
ratio of 1 to 1 for the treatment groups to assess the analgesic efficacy of adding the iPACK
(injection between the popliteal artery and the capsule of the knee) in addition to the
adductor canal block (ACB) for Total Knee Arthoplasty patients (TKA).
ratio of 1 to 1 for the treatment groups to assess the analgesic efficacy of adding the iPACK
(injection between the popliteal artery and the capsule of the knee) in addition to the
adductor canal block (ACB) for Total Knee Arthoplasty patients (TKA).
Inclusion Criteria:
- Patients scheduled for total knee arthroplasty
- American Society Anesthesiologists (ASA) physical status I- III.
- Mentally competent and able to give consent for enrollment in the study.
Exclusion Criteria:
- Patient refusal,
- allergy to local anesthetics, systemic opioids (fentanyl, morphine, hydromorphone, and
any of the drugs included in the multimodal perioperative pain protocol (MP3).
- Revision surgery will be excluded.
- Impaired kidney functions
- patient with coagulopathy will be also excluded.
- Chronic pain syndromes and patients with chronic opioid use in excess of a daily
morphine equivalent dose (MED) of 40mg or greater for the past 3 months prior to the
surgery.
- BMI of 45 or more
We found this trial at
1
site
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials
